Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of [<sup>68</sup>Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial.

The Lancet. Oncology·2026

Same author

Cryoneurolysis of auriculotemporal nerve for treatment of otalgia.

BMJ case reports·2026

Same author

Colocalization of Dopamine D1 and D2 Receptors With Neuronal Nitric Oxide Synthase in the Rat Paraventricular Nucleus: A Structural Basis for Dopaminergic-Nitrergic Interaction.

Anatomia, histologia, embryologia·2026

Same author

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study.

The Lancet. Oncology·2026

Same author

Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials.

The Lancet. Oncology·2026

Same author

Quality and Usability of Prostate Cancer Information Generated by Artificial Intelligence Chatbots: A Comparative Analysis.

Cancers·2026

Same journal

Cytokine Profiles in Myasthenia Gravis Subgroups and the Lack of Any Effect of Immunosuppression.

Muscle & nerve·2026

Same journal

Fatigue in Myasthenia Gravis: Recent Advances and Emerging Concepts.

Muscle & nerve·2026

Same journal

Presynaptic Congenital Myasthenic Syndromes.

Muscle & nerve·2026

Same journal

AGRN-, LRP4-, MUSK-Related CMS: Clinical, Neurophysiological, Morphological, Genetic and Pathological Mechanisms.

Muscle & nerve·2026

Same journal

The Differing Phenotypes of the Three Most Common Postsynaptic Congenital Myasthenic Syndromes Governed by Their Underlying Molecular Pathogenic Mechanisms.

Muscle & nerve·2026

Same journal

IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.

Muscle & nerve·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 15, 2025

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Published on: August 30, 2016

Management Approaches to Spastic Gait Disorders.

Sheng Li^1,2, Tulsi Pandat^1,2, Bradley Chi^1,2

¹Department of Physical Medicine and Rehabilitation, McGovern Medical School, University of Texas Health Science Center - Houston, Houston, Texas, USA.

|April 8, 2025

Summary

This summary is machine-generated.

Understanding spastic gait involves differentiating spasticity from weakness and considering pelvic and knee abnormalities. Effective management requires individualized, concurrent treatments tailored to patient needs and disease progression.

Keywords:

botulinum toxin cerebral palsy gait nerve block robotics spasticity spinal cord injury stroke traumatic brain injury

More Related Videos

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Published on: March 4, 2018

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

Related Experiment Videos

Last Updated: May 15, 2025

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb

Published on: August 30, 2016

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Published on: March 4, 2018

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

Area of Science:

Neurology
Biomechanics
Physical Therapy

Background:

Spastic gait results from upper motor neuron syndromes and neuromuscular diseases, characterized by spasticity, weakness, and abnormal synergies.
Differentiating primary causes like weakness versus spasticity is crucial for understanding gait disorder phenotypes.
Pelvic and knee joint abnormalities significantly influence gait presentation and compensatory mechanisms.

Purpose of the Study:

To elucidate the complex factors contributing to spastic gait disorders.
To emphasize the importance of distinguishing between spasticity and weakness as primary gait impairments.
To review current and investigational treatment strategies for spastic gait.

Main Methods:

Clinical observation and analysis of spastic gait phenotypes.
Diagnostic nerve blocks and instrumented gait analysis for accurate diagnosis.
Review of existing and emerging therapeutic interventions.

Main Results:

Spastic gait is a multifactorial condition influenced by neurological deficits and biomechanical factors.
Pelvic and knee abnormalities play key roles in gait compensation and presentation.
A broad range of treatments, from therapeutic exercise to surgical interventions and neuromodulation, are available.

Conclusions:

Individualized care plans integrating various concurrent treatments are essential for managing spastic gait.
Treatment selection should be based on thorough evaluation, patient input, and goal setting.
Regular re-evaluation of treatment effectiveness is critical, especially for progressive diseases like amyotrophic lateral sclerosis.